SPOROS BIOVENTURES
Sporos Bioventures is a biotechnology firm that focuses on oncology, fibrosis, inflammation, and autoimmune and infection therapeutics. For patients with cancer and immune diseases, Sporos is transforming knowledge into a new hope. Sporos' team of accomplished leaders identifies novel disease mechanisms and catalyzes the development of breakthrough medicines by leveraging our extensive network, strategic resources, and operational expertise.
SPOROS BIOVENTURES
Social Links:
Industry:
Biotechnology Therapeutics
Founded:
2020-01-01
Status:
Active
Total Funding:
38.1 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Tag Manager WordPress Sitelinks Search Box Yoast WordPress SEO Plugin Yoast Plugins Yoast SEO Premium
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-06-15 | Tvardi Therapeutics | Sporos Bioventures investment in Series B - Tvardi Therapeutics | 72.42 M USD |
| 2021-06-03 | Stellanova Therapeutics | Sporos Bioventures investment in Series A - Stellanova Therapeutics | 15.5 M USD |
| 2021-05-25 | Asylia Therapeutics | Sporos Bioventures investment in Series A - Asylia Therapeutics | 14.5 M USD |
| 2021-01-26 | Nirogy Therapeutics | Sporos Bioventures investment in Series A - Nirogy Therapeutics | 16.5 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2021-09-29 | Sporos Bioventures Appoints Amit Rakhit, M.D. as Chief Executive Officer |
More informations about "Sporos Bioventures"
Developing Targeted Cancer Treatments | Sporos …
Sporos Bioventures, LLC is a private biotechnology company focused on transforming the drug development process across oncology through its portfolio approach. Sporos Bioventures owns equity interests in several biopharma …See details»
Developing Targeted Cancer Treatments | Sporos BioDiscovery
Apr 17, 2023 View Presentation Mar 6, 2024 Sporos BioDiscovery to Present Preclinical Findings on SPR1, a Next-Generation TEAD Inhibitor, at the American Association for Cancer …See details»
Sporos Bioventures - Crunchbase Company Profile & Funding
Sporos Bioventures is a biotechnology firm that aims to catalyze the rapid and accurate development of cancer and immune disease treatments.See details»
Sporos Bioventures - 2025 Company Profile & Team - Tracxn
Sporos Bioventures is a series A company based in Houston (United States), founded in 2020 by Joseph Kekst and Peter Feinberg. It operates as a Developer of therapies for cancer and …See details»
Sporos Bioventures | VentureRadar
Sporos identifies novel disease mechanisms and strategically deploys talent, capital and access to operational resources to catalyze the development of breakthrough medicines. Its current …See details»
Programs and Pipeline | Sporos BioDiscovery
Sporos and our group of portfolio companies are advancing a diversified pipeline of potential breakthrough cancer and serious immune disease therapies.See details»
Sporos Bioventures Announces Formation of Strategic Advisory …
HOUSTON, Texas., January 11, 2022 — Sporos Bioventures, LLC, (“Sporos” or the “Company”) a private biotechnology company catalyzing the rapid development of potential breakthrough …See details»
Sporos Bioventures - teaserclub.com
Sporos Bioventures is a biotechnology company based in Houston, Texas, established in 2020. The firm specializes in developing therapeutics for oncology, fibrosis, inflammation, and …See details»
Sporos Launches with $38.1 Million Series A Financing - Sporos …
May 6, 2021 Sporos Launches with $38.1 Million Series A Financing May 6, 2021 | Press Releases Company intends to develop and extend its diverse pipeline of therapies for cancer …See details»
Sporos Bioventures - Funding, Financials, Valuation & Investors
Sporos Bioventures is a biotechnology firm that aims to catalyze the rapid and accurate development of cancer and immune disease treatments.See details»
Sporos Bioventures Appoints Amit Rakhit, M.D. as Chief Executive ...
HOUSTON, Texas., September 29, 2021 — Sporos Bioventures, LLC, a private biotechnology company catalyzing the rapid development of breakthrough therapies through a portfolio of …See details»
Sporos Bioventures | VentureRadar
Sporos identifies novel disease mechanisms and strategically deploys talent, capital and access to operational resources to catalyze the development of breakthrough medicines.See details»
Sporos Bioventures - 2025 Funding Rounds & List of Investors
Jun 16, 2025 Sporos Bioventures has raised a total funding of $38.1M over 1 round from 3 investors. Investors include MBX Capital, AIM-HI Accelerator Fund and 1 other. Their latest …See details»
Sporos Bioventures Raises $38.1M in Series A Financing
May 6, 2021 Sporos Bioventures, LLC, a Houston, TX-based company formed to catalyze the development of therapies that target novel disease mechanisms in cancer and immune …See details»
Sporos Bioventures Appoints Dr. Rachel Humphrey to Board of …
Jan 4, 2022 About Sporos Sporos Bioventures is a private biotechnology company that aims to transform and accelerate the drug development process. Sporos’ pipeline of assets, which …See details»
Sporos Launches with $38.1 Million Series A Financing - Sporos …
May 6, 2021 Leadership team includes founding chief financial officer Michael Wyzga, formerly of Genzyme HOUSTON, Texas., May 6, 2021— Sporos Bioventures, LLC (the “Company” or …See details»
News & Events - Sporos BioDiscovery
Apr 12, 2024 Keep up to date with Sporos Bioventures' events, presentations, and press releases.See details»
Sporos Bioventures - Investments, Portfolio & Company Exits
Sporos Bioventures is a biotechnology firm that aims to catalyze the rapid and accurate development of cancer and immune disease treatments.See details»
Contact | Sporos BioDiscovery
Contact Sporos Bioventures by filling out this online form and one of our team members will get back to you.See details»
Sporos Bioventures - Growth Outlook - Crunchbase
Sporos Bioventures is a biotechnology firm that aims to catalyze the rapid and accurate development of cancer and immune disease treatments.See details»